Hbk Sorce Advisory LLC Genmab A/S Transaction History

Hbk Sorce Advisory LLC

$2.56 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$27.94 - $35.44 $57,724 - $73,219	-2,066 Reduced 22.61%	7,073 $225,000
Q3 2023 Nov 06, 2023	BUY	$35.27 - $42.24 $14,778 - $17,698	419 Added 4.81%	9,139 $322,000
Q2 2023 Aug 04, 2023	SELL	$37.4 - $42.94 $369,586 - $424,333	-9,882 Reduced 53.12%	8,720 $331,000
Q1 2023 Aug 15, 2023	BUY	$34.88 - $43.22 $10,952 - $13,571	314 Added 3.6%	9,034 $341,000
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $8,092 - $10,027	232 Added 1.26%	18,602 $1.05 Million
Q4 2022 Feb 09, 2023	BUY	$33.8 - $47.06 $265,025 - $368,997	7,841 Added 74.47%	18,370 $779,000
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $113,251 - $1.34 Million	3,593 Added 51.8%	10,529 $338,000
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $24,066 - $34,597	-897 Reduced 11.45%	6,936 $225,000
Q1 2022 May 13, 2022	BUY	$30.95 - $39.68 $34,199 - $43,846	1,105 Added 16.42%	7,833 $283,000
Q4 2021 Feb 15, 2022	SELL	$35.87 - $47.12 $25,001 - $32,842	-697 Reduced 9.39%	6,728 $266,000
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $38,350 - $44,968	923 Added 14.2%	7,425 $324,000
Q2 2021 Aug 12, 2021	SELL	$32.88 - $44.57 $34,852 - $47,244	-1,060 Reduced 14.02%	6,502 $265,000
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $5,503 - $7,903	178 Added 2.41%	7,562 $248,000
Q4 2020 Feb 12, 2021	SELL	$33.66 - $40.76 $31,808 - $38,518	-945 Reduced 11.35%	7,384 $300,000
Q3 2020 Nov 13, 2020	SELL	$33.07 - $38.68 $71,497 - $83,626	-2,162 Reduced 20.61%	8,329 $305,000
Q2 2020 Aug 14, 2020	SELL	$20.05 - $33.89 $54,415 - $91,977	-2,714 Reduced 20.55%	10,491 $356,000
Q1 2020 May 15, 2020	BUY	$17.15 - $25.22 $2,160 - $3,177	126 Added 0.96%	13,205 $280,000
Q4 2019 Feb 13, 2020	SELL	$18.88 - $24.14 $113 - $144	-6 Reduced 0.05%	13,079 $292,000
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $235,530 - $279,757	13,085 New	13,085 $265,000

Others Institutions Holding GMAB

# of Institutions

234

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$317 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$107 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$92.7 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$64.3 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$48.4 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.8B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account